{"id":"discontinuation-antipsychotic-treatment","safety":{"commonSideEffects":[{"rate":null,"effect":"Psychotic relapse or symptom recurrence"},{"rate":null,"effect":"Withdrawal-emergent dyskinesia"},{"rate":null,"effect":"Rebound psychosis"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is not a drug itself, but rather a clinical study design (Phase 3) investigating what happens when antipsychotic treatment is stopped in patients. The trial likely examines relapse rates, symptom recurrence, safety, and outcomes associated with antipsychotic discontinuation versus continuation in conditions like schizophrenia or bipolar disorder.","oneSentence":"This is a clinical trial protocol studying the effects of discontinuing antipsychotic medication in patients currently treated with antipsychotics.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:09:37.106Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Evaluation of antipsychotic discontinuation outcomes in schizophrenia or related psychotic disorders"},{"name":"Assessment of relapse risk and symptom recurrence following antipsychotic withdrawal"}]},"trialDetails":[{"nctId":"NCT05356013","phase":"PHASE2","title":"Caplyta in Borderline Personality Disorder","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2023-05-10","conditions":"Borderline Personality Disorder","enrollment":60},{"nctId":"NCT06433635","phase":"PHASE4","title":"Sequential Multiple Assignment Randomized Trial for Bipolar Depression","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2024-10-01","conditions":"Bipolar I Disorder, Depression","enrollment":2726},{"nctId":"NCT06333990","phase":"PHASE3","title":"Quetiapine to Reduce Post Concussive Syndrome After Mild Traumatic Brain Injury (mTBI)","status":"RECRUITING","sponsor":"Foundation for Advancing Veterans' Health Research","startDate":"2024-07-09","conditions":"Mild Traumatic Brain Injury","enrollment":146},{"nctId":"NCT05667961","phase":"","title":"Predictors of Functional Remission in Discharged Patients With Schizophrenia After Long-term Drug Discontinuation","status":"COMPLETED","sponsor":"Shanghai Mental Health Center","startDate":"2022-09-15","conditions":"Schizophrenia","enrollment":480},{"nctId":"NCT02515773","phase":"PHASE4","title":"Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs","status":"COMPLETED","sponsor":"Melissa Delbello","startDate":"2015-12","conditions":"Bipolar Disorder","enrollment":1565},{"nctId":"NCT05830708","phase":"NA","title":"The Efficacy of Probiotics for the Treatment of Alcohol Use Disorder Among Adult Males","status":"NOT_YET_RECRUITING","sponsor":"Universiti Sains Malaysia","startDate":"2023-05-01","conditions":"Alcohol Use Disorder","enrollment":120},{"nctId":"NCT03559426","phase":"PHASE4","title":"Research Into Antipsychotic Discontinuation and Reduction Trial","status":"COMPLETED","sponsor":"University College, London","startDate":"2016-03-24","conditions":"Schizophrenia, Schizoaffective Disorder, Delusional Disorder","enrollment":253},{"nctId":"NCT01584466","phase":"NA","title":"Long Acting Paliperidone in Dually Diagnosed People With Schizophrenia: An Open-label Pilot Study","status":"WITHDRAWN","sponsor":"University of Maryland, Baltimore","startDate":"2014-01","conditions":"Schizophrenia","enrollment":""},{"nctId":"NCT01030874","phase":"NA","title":"Orthostatic Hypotension Treatment on Rehab Unit","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2011-10","conditions":"Orthostatic Hypotension, Falls","enrollment":356},{"nctId":"NCT03090490","phase":"NA","title":"10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals","status":"UNKNOWN","sponsor":"Fundación Marques de Valdecilla","startDate":"2014-09","conditions":"Schizophrenia, Schizophrenia Relapse, Schizophrenia Spectrum and Other Psychotic Disorders","enrollment":68},{"nctId":"NCT02884518","phase":"NA","title":"Predicting Antipsychotic Discontinuation in Psychosis","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2016-10-04","conditions":"Schizophrenia","enrollment":35},{"nctId":"NCT03130465","phase":"","title":"Aripiprazole Once-monthly Versus Daily Oral Atypical Antipsychotic Treatment in Patients With Recent-onset Schizophrenia","status":"UNKNOWN","sponsor":"Otsuka Pharmaceutical Europe Ltd","startDate":"2017-07-13","conditions":"Schizophrenia","enrollment":636},{"nctId":"NCT03887754","phase":"PHASE2","title":"Therapeutic Issues for Autism","status":"COMPLETED","sponsor":"Minia University","startDate":"2016-01","conditions":"Autism Spectrum Disorder","enrollment":80},{"nctId":"NCT02307396","phase":"PHASE4","title":"Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients","status":"COMPLETED","sponsor":"Technical University of Munich","startDate":"2015-02-01","conditions":"Schizophrenia, Schizophrenia and Disorders With Psychotic Features, Schizoaffective Disorders","enrollment":21},{"nctId":"NCT00156715","phase":"PHASE4","title":"Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder","status":"COMPLETED","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2004-03","conditions":"Schizophrenia, Schizoaffective Disorder, Psychotic Disorder","enrollment":23},{"nctId":"NCT00272597","phase":"PHASE4","title":"Risperidone LA Heathcare Resource Study","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2005-09","conditions":"Psychosis, Schizophrenia","enrollment":30},{"nctId":"NCT00806234","phase":"PHASE4","title":"Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2009-01","conditions":"Psychotic Disorders","enrollment":127},{"nctId":"NCT01174290","phase":"PHASE4","title":"Preventing ICU Subsyndromal Delirium Conversion to Delirium With Haloperidol","status":"COMPLETED","sponsor":"Northeastern University","startDate":"2010-09","conditions":"Subsyndromal Delirium","enrollment":68},{"nctId":"NCT02220504","phase":"NA","title":"3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals","status":"COMPLETED","sponsor":"Fundación Marques de Valdecilla","startDate":"2004-07","conditions":"Schizophrenia, Schizophrenia Relapse, Schizophrenia Spectrum and Other Psychotic Disorders","enrollment":68},{"nctId":"NCT01947803","phase":"PHASE4","title":"A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia","status":"COMPLETED","sponsor":"Xian-Janssen Pharmaceutical Ltd.","startDate":"2013-09","conditions":"Schizophrenia","enrollment":353},{"nctId":"NCT02137278","phase":"PHASE3","title":"Stop Vasodepressor Drugs in Reflex Syncope","status":"COMPLETED","sponsor":"Gruppo Italiano Multidisciplinare per lo Studio della Sincope","startDate":"2014-03","conditions":"Hypotensive Syncope","enrollment":58},{"nctId":"NCT01977300","phase":"PHASE3","title":"Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2003-01","conditions":"Bipolar I Disorder","enrollment":159},{"nctId":"NCT01929889","phase":"PHASE4","title":"Assessing the Effects of Fanapt® on Social Cognition in Schizophrenia","status":"TERMINATED","sponsor":"Northwestern University","startDate":"2012-04","conditions":"Schizophrenia, Schizoaffective Disorder","enrollment":19},{"nctId":"NCT00194038","phase":"PHASE4","title":"Aripiprazole in Late Life Bipolar Disorder","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2004-04","conditions":"Bipolar Disorder","enrollment":20},{"nctId":"NCT01765829","phase":"PHASE3","title":"Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis","status":"UNKNOWN","sponsor":"Fundación Pública Andaluza Progreso y Salud","startDate":"2012-11","conditions":"Psychosis Nos/Other","enrollment":104},{"nctId":"NCT02142556","phase":"PHASE3","title":"The Efficacy and Safety of Quetiapine XR in Patients With Schizophrenia Switched From Other Antipsychotics","status":"COMPLETED","sponsor":"Tri-Service General Hospital","startDate":"2008-11","conditions":"Schizophrenia","enrollment":61},{"nctId":"NCT00378092","phase":"PHASE4","title":"A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic Episode","status":"COMPLETED","sponsor":"Janssen Cilag N.V./S.A.","startDate":"2006-04","conditions":"Schizophrenia","enrollment":33},{"nctId":"NCT00417482","phase":"PHASE4","title":"Antipsychotic Discontinuation in Alzheimer's Disease","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2004-08","conditions":"Alzheimer Disease, Psychotic Disorders, Agitation","enrollment":180},{"nctId":"NCT00833300","phase":"NA","title":"Haloperidol vs Olanzapine for the Management of ICU Delirium","status":"TERMINATED","sponsor":"Richard Hall","startDate":"2008-06","conditions":"Delirium, Agitation","enrollment":200},{"nctId":"NCT00973297","phase":"NA","title":"A Targeted Falls Prevention Program in Rehabilitation In-Patients","status":"UNKNOWN","sponsor":"Hadassah Medical Organization","startDate":"2009-11","conditions":"Accidental Falls","enrollment":100},{"nctId":"NCT00159120","phase":"PHASE4","title":"Maintenance Treatment vs. Stepwise Drug Discontinuation in First-Episode Schizophrenia","status":"COMPLETED","sponsor":"Heinrich-Heine University, Duesseldorf","startDate":"2001-11","conditions":"Schizophrenia, Psychoses","enrollment":71},{"nctId":"NCT00159133","phase":"PHASE4","title":"Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepines in First-Episode Schizophrenia","status":"COMPLETED","sponsor":"Heinrich-Heine University, Duesseldorf","startDate":"2001-11","conditions":"Schizophrenia, Psychoses","enrollment":71}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":371,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Aripiprazole","Olanzapine","Zuclopenthixol","Clotiapine","Flupentixol"],"phase":"phase_3","status":"active","brandName":"Discontinuation antipsychotic treatment","genericName":"Discontinuation antipsychotic treatment","companyName":"Fundación Pública Andaluza Progreso y Salud","companyId":"fundaci-n-p-blica-andaluza-progreso-y-salud","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a clinical trial protocol studying the effects of discontinuing antipsychotic medication in patients currently treated with antipsychotics. Used for Evaluation of antipsychotic discontinuation outcomes in schizophrenia or related psychotic disorders, Assessment of relapse risk and symptom recurrence following antipsychotic withdrawal.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}